Skip to main content

Find Clinical Trials

Home
Conditions
Poxviridae Infections

Clinical trial condition

Poxviridae Infections

Explore clinical trials studying Poxviridae Infections. Study availability and eligibility vary by location and protocol.

164 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Poxviridae Infections trial results

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

NCT01169584

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Ewing's Sarcoma, +54 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +36 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

NCT00625456

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
Locations: Billings Clinic Billings, Montana, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Cancer Centers of the Carolinas Greenville, South Carolina, United States

Ottawa Health Research Institute Ottawa, Ontario, Canada

View Trial Details

Completed

Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum

NCT01348386

Conditions: DNA Virus Infections, Infections, Molluscum Contagiosum, +6 more
Locations: CAP Rambla Ferran Lleida, Catalonia, Spain

View Trial Details

Completed

Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer

NCT01584284

Conditions: Cancer of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, +11 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

View Trial Details

Completed

Phase I Trial of an Investigational Small Pox Medication

NCT00728689

Conditions: Animal Diseases, DNA Virus Infections, Infections, +8 more
Locations: Orlando Clinical Research Center Orlando, Florida, United States

View Trial Details

Completed

VHA Clinicians and Bioterror Events: Interactive Web-based Learning

NCT00123396

Conditions: Anthrax, Bacillaceae Infections, Bacterial Infections, +7 more
Locations: Birmingham VA Medical Center, Birmingham, AL Birmingham, Alabama, United States

Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States

VA Loma Linda Healthcare System, Loma Linda, CA Loma Linda, California, United States

James A. Haley Veterans' Hospital, Tampa, FL Tampa, Florida, United States

View Trial Details

Completed

ACAM 3000 MVA at Harvard Medical School

NCT00133575

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: Brigham and Women's Hospital - Infectious Diseases Boston, Massachusetts, United States

View Trial Details

Completed

Combination Study With MVA BN and Dryvax

NCT00082446

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: Saint Louis University St Louis, Missouri, United States

View Trial Details

Completed

Expanded Dryvax Dilution Study in Previously Vaccinated Adults

NCT00050505

Conditions: DNA Virus Infections, Infections, Poxviridae Infections, +2 more
Locations: Kaiser Permanente Vaccine Study Center Oakland, California, United States

Stanford University Stanford, California, United States

UCLA Center For Vaccine Research Torrance, California, United States

University of Maryland Baltimore Baltimore, Maryland, United States

View Trial Details